Medical Research News and Research

RSS

EHIL creates new software tool to protect health research participants' privacy

In recognition of Data Privacy Day 2011, the Electronic Health Information Laboratory is making a new software tool freely available to the medical research community to protect personal privacy while helping to advance medical research.

28 Jan 2011

H3 Biomedicine introduces cancer research and development operations in Cambridge

H3 Biomedicine today announced that it has launched research and development operations in Cambridge, Massachusetts. H3 Biomedicine will undertake a comprehensive approach to breakthrough oncology treatments based on two primary principles: 1) the genetics of patients' cancers can reveal drug targets tailored to their cancers and 2) the advances in modern chemistry enable the discovery of new classes of safe and effective drugs against these targets.

27 Jan 2011

Gestational diabetes raises risk of diabetes and weight problems in babies: Study

The latest Australian research suggests that women who have diabetes during pregnancy – also known as gestational diabetes, are more likely to have children who will battle diabetes and weight problems through their lives. The research is published in the journal Diabetologia, now online.

27 Jan 2011

CHUV university hospital to implement OpenTrust Crypt'n'Share for secure exchange of sensitive information

OpenTrust, the Next-Gen IT security software publisher, today announced that the CHUV university hospital in Lausanne has chosen to use OpenTrust Crypt'n'Share to securely exchange sensitive information throughout the establishment.

27 Jan 2011

Fixed Phage to develop products based on Strathclyde's technology for tackling infections

A new company has been launched to commercialise an award-winning technology, developed at the University of Strathclyde in Glasgow, for tackling bacterial infection and contamination, including superbugs such as MRSA.

25 Jan 2011

Breakthrough in understanding mechanisms behind hereditary alpha-1-antitrypsin deficiency

Researchers from the Royal College of Surgeons in Ireland (RCSI) and Beaumont Hospital have made a breakthrough in understanding the mechanisms behind the most severe form of hereditary emphysema and how protein treatments can improve the condition. The findings of this study may also lead to new treatments for patients with smoker's emphysema.

24 Jan 2011

Cell binding mechanism can lead to new treatments for skin diseases, lethal heart defects

A University of Manchester scientist has revealed the mechanism that binds skin cells tightly together, which he believes will lead to new treatments for painful and debilitating skin diseases and also lethal heart defects.

From The University of Manchester 21 Jan 2011

PROSPECT trial results shed new light on plaque types that cause unexpected heart attacks

Results from the PROSPECT clinical trial shed new light on the types of vulnerable plaque that are most likely to cause sudden, unexpected adverse cardiac events, and on the ability to identify them through imaging techniques before they occur.

21 Jan 2011

Malaria parasite caught in action on film for the first time

Australian researchers have managed to take pictures of microscopic malaria parasite as it invades a human red blood cell. This will provide a deeper understanding of the parasite’s behaviour and may help fight it. Up to 10% of the world’s population contract malaria every year and a million people, mostly pregnant women and children, die as a result of the parasite transmitted by infected mosquitoes.

19 Jan 2011

Point Of Care Solutions introduces AMP for physicians to manage medical practices

Point of Care Solutions introduces its Agile Medical Platform, the latest integrated practice management and ambulatory Electronic Health Record system available in the United States to manage physician medical practices with a ubiquitous interface.

19 Jan 2011

Alternative interventions do just as well as cognitive interventions for reducing 'senior moments'

Trying to stave off senior moments with memory drills and similar brain-boosting activities? A new evidence review suggests that these specific training regimes are not any better than simple conversations at improving memory in older adults.

19 Jan 2011

Meganucleases used to prevent HSV-1 infection

Cellectis, announced today that scientists from Cellectis therapeutics, the French National Center For Medical Research (CNRS) and Institut de la Vision (Paris) have used its proprietary meganucleases to successfully prevent infection of cultured cells by a Herpes Simplex virus (HSV-1).

19 Jan 2011

New patented technique offers unprecedented view of DNA damage

New technology providing the first view of DNA damage throughout the entire human genome developed by Cardiff University scientists could offer a valuable new insight into the development and treatment of conditions like cancer.

19 Jan 2011

More studies needed to evaluate harm or benefit of mechanical CPR

Pushing on the chest to simulate the heart's rhythmic pumping action is an essential part of cardiopulmonary resuscitation after cardiac arrest. In recent decades, manufacturers have developed several mechanical devices that claim to perform CPR more effectively than human efforts alone.

19 Jan 2011

Study may help develop novel ways to combat lipotoxic cardiomyopathy, related heart disease

A team led by Rolf Bodmer, Ph.D. at Sanford-Burnham Medical Research Institute recently unraveled an alternative pathway to lipotoxic cardiomyopathy in fruit flies - a genetic mechanism that occurs independently of a diet high in fat.

19 Jan 2011

RTS,S offers 46 percent protection against malaria for at least 15 months after vaccination, Study finds

A Phase II trial published Friday in Lancet Infectious Diseases has shown that RTS,S, the "experimental malaria vaccine from GlaxoSmithKline provides African children with long-lasting protection" against malaria, Reuters reports.

18 Jan 2011

OMJPI, Sanford-Burnham enter agreement to discover compounds for Alzheimer's disease, psychiatric disorders

Sanford-Burnham Medical Research Institute has entered into a collaboration with Ortho-McNeil-Janssen Pharmaceuticals, Inc., to discover compounds for Alzheimer's disease and major psychiatric disorders.

18 Jan 2011

T3SS-dependent bacteria may be a suitable point of attack for future antibiotics: Study

So-called type-3 secretion systems of pathogenic bacteria may be a suitable point of attack for future antibiotics. This is shown by Professor Maria Fällman and her associates at Umeå University in Sweden in the Proceeding of the National Academy of Sciences, PNAS, in the US.

18 Jan 2011

US Army awards $2.8M contract for project focusing on brain and eye injuries in military personnel

The Virginia Tech-Wake Forest University Center for Injury Biomechanics (www.cib.vt.edu) has been awarded a $2.8 million contract from the U.S. Army Medical Research and Materiel Command for phase 2 of an overall project focusing on brain and eye injuries in military personnel. Specifically, blast induced brain trauma will be investigated using experimental and computational models.

14 Jan 2011

Scientists develop Australia's first pluripotent stem cell lines using skin biopsies for FA disease

Scientists have developed Australia's first adult induced pluripotent stem cell lines using skin biopsies from patients with the rare genetic disease Friedreich Ataxia.

14 Jan 2011

Medical Research News and Research

EHIL creates new software tool to protect health research participants' privacy

H3 Biomedicine introduces cancer research and development operations in Cambridge

Gestational diabetes raises risk of diabetes and weight problems in babies: Study

CHUV university hospital to implement OpenTrust Crypt'n'Share for secure exchange of sensitive information

Fixed Phage to develop products based on Strathclyde's technology for tackling infections

Breakthrough in understanding mechanisms behind hereditary alpha-1-antitrypsin deficiency

Cell binding mechanism can lead to new treatments for skin diseases, lethal heart defects

PROSPECT trial results shed new light on plaque types that cause unexpected heart attacks

Malaria parasite caught in action on film for the first time

Point Of Care Solutions introduces AMP for physicians to manage medical practices

Alternative interventions do just as well as cognitive interventions for reducing 'senior moments'

Meganucleases used to prevent HSV-1 infection

New patented technique offers unprecedented view of DNA damage

More studies needed to evaluate harm or benefit of mechanical CPR

Study may help develop novel ways to combat lipotoxic cardiomyopathy, related heart disease

RTS,S offers 46 percent protection against malaria for at least 15 months after vaccination, Study finds

OMJPI, Sanford-Burnham enter agreement to discover compounds for Alzheimer's disease, psychiatric disorders

T3SS-dependent bacteria may be a suitable point of attack for future antibiotics: Study

US Army awards $2.8M contract for project focusing on brain and eye injuries in military personnel

Scientists develop Australia's first pluripotent stem cell lines using skin biopsies for FA disease

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News